[Endothelin].
Kanno
Kazuo
K
Division of Endocrinology and Metabolism, Department of Medicine, Musashino Red Cross Hospital.
Hirata
Yukio
Y
D000818:Animals; D001161:Arteriosclerosis / Q000175:diagnosis; D015415:Biomarkers / Q000097:blood; D000077300:Bosentan; D003940:Diagnostic Techniques, Endocrine; D015195:Drug Design; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000097:blood* / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D006333:Heart Failure / Q000175:diagnosis; D006801:Humans; D006973:Hypertension / Q000175:diagnosis; D006976:Hypertension, Pulmonary / Q000175:diagnosis; D017466:Receptors, Endothelin / Q000502:physiology; D012016:Reference Values; D013449:Sulfonamides
D015415:Biomarkers; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D017466:Receptors, Endothelin; D013449:Sulfonamides; D000077300:Bosentan